Vaccinex VCNX Stock
Vaccinex Price Chart
Vaccinex VCNX Financial and Trading Overview
| Vaccinex stock price | 0.6 USD |
| Previous Close | 0.45 USD |
| Open | 0.46 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.4 - 0.46 USD |
| 52 Week Range | 0.34 - 1.5 USD |
| Volume | 132.05K USD |
| Avg. Volume | 145.61K USD |
| Market Cap | 28.73M USD |
| Beta (5Y Monthly) | 1.019885 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 7.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VCNX Valuation Measures
| Enterprise Value | 21.91M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.142857 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 34.8192 |
| Price/Book (mrq) | 10 |
| Enterprise Value/Revenue | 26.558 |
| Enterprise Value/EBITDA | -1.09 |
Trading Information
Vaccinex Stock Price History
| Beta (5Y Monthly) | 1.019885 |
| 52-Week Change | -58.87% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.5 USD |
| 52 Week Low | 0.34 USD |
| 50-Day Moving Average | 0.4 USD |
| 200-Day Moving Average | 0.53 USD |
VCNX Share Statistics
| Avg. Volume (3 month) | 145.61K USD |
| Avg. Daily Volume (10-Days) | 174.05K USD |
| Shares Outstanding | 65.29M |
| Float | 27.2M |
| Short Ratio | 0.47 |
| % Held by Insiders | 11.87% |
| % Held by Institutions | 54.60% |
| Shares Short | 99.45K |
| Short % of Float | 0.25% |
| Short % of Shares Outstanding | 0.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2460.36% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -110.23% |
| Return on Equity (ttm) | -217.15% |
Income Statement
| Revenue (ttm) | 825K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -13704000 USD |
| EBITDA | -20101000 USD |
| Net Income Avi to Common (ttm) | -20182000 USD |
| Diluted EPS (ttm) | -0.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.32M USD |
| Total Cash Per Share (mrq) | 0.06 USD |
| Total Debt (mrq) | 427K USD |
| Total Debt/Equity (mrq) | 17.79 USD |
| Current Ratio (mrq) | 1.913 |
| Book Value Per Share (mrq) | 0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19118000 USD |
| Levered Free Cash Flow (ttm) | -11772875 USD |
Profile of Vaccinex
| Country | United States |
| State | NY |
| City | Rochester |
| Address | 1895 Mount Hope Avenue |
| ZIP | 14620 |
| Phone | 585 271 2700 |
| Website | https://www.vaccinex.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 38 |
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Q&A For Vaccinex Stock
What is a current VCNX stock price?
Vaccinex VCNX stock price today per share is 0.6 USD.
How to purchase Vaccinex stock?
You can buy VCNX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vaccinex?
The stock symbol or ticker of Vaccinex is VCNX.
Which industry does the Vaccinex company belong to?
The Vaccinex industry is Biotechnology.
How many shares does Vaccinex have in circulation?
The max supply of Vaccinex shares is 2.68M.
What is Vaccinex Price to Earnings Ratio (PE Ratio)?
Vaccinex PE Ratio is 0.08086254 now.
What was Vaccinex earnings per share over the trailing 12 months (TTM)?
Vaccinex EPS is 7.42 USD over the trailing 12 months.
Which sector does the Vaccinex company belong to?
The Vaccinex sector is Healthcare.
Vaccinex VCNX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Capital Market Composite RCMP | 92.16 USD — |
-4.45
|
— — | 89.57 USD — | 93.85 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}